From Sourcing to Exit:
A Healthcare Commercialisation Platform
An Investment Platform With Extended Operational Capabilities
Our structured approach spans the complete investment journey: Source, Engage and Invest, Operational Support, Scale and Monitor, and Exit.
Source
Sector Knowledge and Healthcare Deal Sourcing
We identify promising post-Series A companies requiring financing through:
- Deep healthcare sector expertise
- Proprietary deal flow via SRI, Aegis and Silicon Valley networks
- International healthcare market relevance filtering
- Initial opportunity assessment
ENGAGE & INVEST
Due Diligence and Capital Deployment
We assess each target risk and upside potential and deploy growth capital through:
- Institutional governance
- A disciplined investment process
- A focus on AI-enabled HealthTech
OPERATIONAL SUPPORT
Hands-On Value Creation
We direct portfolio companies to improve their positioning and operations, with support including:
- Growth capital to scale operations and market entry
- Strategic guidance and governance
- Regulatory navigation in new markets
- Management team coaching
- Commercial pilot facilitation
SCALE & MONITOR
Market Expansion and KPI Governance
Our strategic phased market entry support uses the UAE as a proof-of-concept market, activating networks including M42 and the Department of Health.
The model can then be replicated in additional Gulf and emerging markets.
Support includes operational KPI tracking and next-round capital bridging.
EXIT
Realising Returns and Impact
Our approach is built around an approximately four-year average holding period and defined exit pathways.
These may include:
- Strategic trade sale or IPO pathways
- M&A advisory and buyer alignment
- Reinvestment of capital into the platform
Governance
Combining Flexibility and Institutional Governance
The Atlas investment strategy is implemented through a closed-ended Actively Managed Certificate (AMC) structure.
The structure combines a vehicle managed by a regulated entity, Mirabaud, with additional flexibility, where decision power remains with the Atlas Strategy Sponsor holding industry knowledge.